Recipharm offers serialization for China regs; Dalton expands Toronto plant; U.S. and China fight over vitamin C

> Recipharm has launched a serialization project for a customer in China. Report

> CDMO Dalton Pharma, supported by a $2 million state grant, has expanded its sterile powder filling capabilities at its plant in Toronto, Canada. Release

> Moorfields Eye Hospital NHS Foundation Trust has decided to close its Moorfields Pharmaceuticals' central London compounding production facility, which suspended operations more than a year ago after an MHRA inspection raised some quality concerns. Release

> Dominance of Chinese makers on the vitamin C ingredient market is being challenged in U.S. court. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.